Autopsy report · NCT04181320
A Multicentre European Study to Evaluate Granulox® Used in the Treatment Pathway of Predominantly Chronic Venous Leg Ulcers (VLUs).
Cause of deathOther
“Results of interim analysis”
Life of this trial
- Registered 7 months before it started.
- Ran for about 2 years 7 months before it stopped.
- 128 participants enrolled.
- Results were posted on the registry 1 year 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Molnlycke Health Care AB
- Sponsor type
- Industry
- Conditions
- Venous Leg Ulcer
- Interventions
- Venous Leg Ulcer Standard of Care with Granulox
- Participants
- 128
- Sites
- 27
- Countries
- Croatia, Czechia, France, Germany, Hungary, Poland, United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.